291 related articles for article (PubMed ID: 7917900)
1. Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1.
Prendiville J; McGown AT; Gescher A; Dickson AJ; Courage C; Pettit GR; Crowther D; Fox BW
Br J Cancer; 1994 Oct; 70(4):573-8. PubMed ID: 7917900
[TBL] [Abstract][Full Text] [Related]
2. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells.
Stanwell C; Gescher A; Bradshaw TD; Pettit GR
Int J Cancer; 1994 Feb; 56(4):585-92. PubMed ID: 8112895
[TBL] [Abstract][Full Text] [Related]
3. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
Szallasi Z; Denning MF; Smith CB; Dlugosz AA; Yuspa SH; Pettit GR; Blumberg PM
Mol Pharmacol; 1994 Nov; 46(5):840-50. PubMed ID: 7969070
[TBL] [Abstract][Full Text] [Related]
4. Structural modifications of bryostatin 2.
Pettit GR; Sengupta D; Blumberg PM; Lewin NE; Schmidt JM; Kraft AS
Anticancer Drug Des; 1992 Apr; 7(2):101-14. PubMed ID: 1575884
[TBL] [Abstract][Full Text] [Related]
5. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
Vrana JA; Saunders AM; Chellappan SP; Grant S
Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
[TBL] [Abstract][Full Text] [Related]
6. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM
Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857
[TBL] [Abstract][Full Text] [Related]
7. Bryostatins selectively regulate protein kinase C-mediated effects on GH4 cell proliferation.
Mackanos EA; Pettit GR; Ramsdell JS
J Biol Chem; 1991 Jun; 266(17):11205-12. PubMed ID: 1904062
[TBL] [Abstract][Full Text] [Related]
8. Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells.
Scala S; Dickstein B; Regis J; Szallasi Z; Blumberg PM; Bates SE
Clin Cancer Res; 1995 Dec; 1(12):1581-7. PubMed ID: 9815959
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
Kennedy MJ; Prestigiacomo LJ; Tyler G; May WS; Davidson NE
Cancer Res; 1992 Mar; 52(5):1278-83. PubMed ID: 1737390
[TBL] [Abstract][Full Text] [Related]
10. Bryostatin 1-tamoxifen combinations show synergistic effects on the inhibition of growth of P388 cells in vitro.
McGown AT; Jayson G; Pettit GR; Haran MS; Ward TH; Crowther D
Br J Cancer; 1998; 77(2):216-20. PubMed ID: 9460991
[TBL] [Abstract][Full Text] [Related]
11. Synergistic action of calcium ionophore A23187 and protein kinase C activator bryostatin 1 on human B cell activation and proliferation.
Drexler HG; Gignac SM; Pettit GR; Hoffbrand AV
Eur J Immunol; 1990 Jan; 20(1):119-27. PubMed ID: 1689659
[TBL] [Abstract][Full Text] [Related]
12. Bryostatin, a non-phorbol macrocyclic lactone, activates intact human polymorphonuclear leukocytes and binds to the phorbol ester receptor.
Berkow RL; Kraft AS
Biochem Biophys Res Commun; 1985 Sep; 131(3):1109-16. PubMed ID: 2996535
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1.
Basu A; Lazo JS
Cancer Res; 1992 Jun; 52(11):3119-24. PubMed ID: 1591725
[TBL] [Abstract][Full Text] [Related]
14. Bryostatin 1 inhibits phorbol ester-induced apoptosis in prostate cancer cells by differentially modulating protein kinase C (PKC) delta translocation and preventing PKCdelta-mediated release of tumor necrosis factor-alpha.
von Burstin VA; Xiao L; Kazanietz MG
Mol Pharmacol; 2010 Sep; 78(3):325-32. PubMed ID: 20516369
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of protein kinase C agonists on prostaglandin production and growth in human breast cancer cells.
Boorne AJ; Donnelly N; Schrey MP
Breast Cancer Res Treat; 1998 Mar; 48(2):117-24. PubMed ID: 9596483
[TBL] [Abstract][Full Text] [Related]
16. Decreased phorbol ester receptor and protein kinase C in P388 murine leukemic cells resistant to etoposide.
Ido M; Sato K; Sakurai M; Inagaki M; Saitoh M; Watanabe M; Hidaka H
Cancer Res; 1987 Jul; 47(13):3460-3. PubMed ID: 3581082
[TBL] [Abstract][Full Text] [Related]
17. The effect of bryostatin on protein kinase C-regulated functions in human T lymphocytes and epidermal keratinocytes.
Galron D; Tamir A; Gelkop S; Grossman N; Isakov N
Immunol Lett; 1993 Dec; 39(1):17-22. PubMed ID: 8144186
[TBL] [Abstract][Full Text] [Related]
18. Varied differentiation responses of human leukemias to bryostatin 1.
Kraft AS; William F; Pettit GR; Lilly MB
Cancer Res; 1989 Mar; 49(5):1287-93. PubMed ID: 2917358
[TBL] [Abstract][Full Text] [Related]
19. p53 and protein kinase C independent induction of growth arrest and apoptosis by bryostatin 1 in a highly metastatic mammary epithelial cell line: In vitro versus in vivo activity.
Wang H; Mohammad RM; Werdell J; Shekhar PV
Int J Mol Med; 1998 Jun; 1(6):915-23. PubMed ID: 9852625
[TBL] [Abstract][Full Text] [Related]
20. Differential modulation of protein kinase C by bryostatin 1 and phorbol ester.
Sako T; Ohshima S; Yoshizumi T; Sakurai M
Tohoku J Exp Med; 1988 Nov; 156(3):229-36. PubMed ID: 3252553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
